Skip to main content

Table 2 Characteristic of 76 adults with HIV treated for pulmonary tuberculosis, Jos, Nigeria (June 2013– June 2015)

From: Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study

Characteristics

Xpert MTB Detected

(n = 56)

Xpert No MTB

Detected (n = 20)

P-value

Age, years,Mean (SD)

37.3 (13.2)

35.0 (12.3)

0.39

Sex

  

0.004

 Male, n (%)

32 (57.1)

4 (20.0)

 

 Female, n (%)

24 (42.9)

16 (80)

 

TB symptoms

   

 Cough > 2 weeks, n (%)

42 (75.0)

14 (70.0)

0.66

 Fever, n (%)

48 (85.7)

14 (70.0)

0.12

 Weight loss, n (%)

52 (92.9)

15 (75.0)

0.03

 Night Sweat, n (%)

45 (80.4)

11 (55)

0.03

Previous TB treatment, n (%)

7 (12.5)

4 (20)

0.4

On ART, n (%)

48 (88.9)

15 (83.3)

0.54

Current CD4 ≤ 200 cells/mm3,n (%)

38 (67.9)

10 (50.0)

0.16

aCD4 count at TB diagnosis, cells/mm3, Median (IQR)

198 (68–354)

309 (123–507)

0.09

SM positive, n (%)

50 (89.3)

7 (35.0)

<0.001

Rifampicin Resistance, n (%)

5 (8.93)

-

-

  1. SD Standard deviation, IQR Interquartile range, TB Tuberculosis, MTB Mycobacterium tuberculosis, ART Antiretroviral Therapy, SM Sputum smear microscopy for acid fast bacilli aKruskal Wallis test